Clot-busting drug benefits intermediate-risk patients with pulmonary embolism
The clot-busting drug tenecteplase prevents death or circulatory collapse in a subgroup of patients with a blood clot in the lungs and appears to be especially useful in patients younger than 75, according to research presented ...
Mar 12, 2013
0
0